Physician

Samia Benslimane Geevarghese, M.D.

According to 2025 Medicare claims, Samia Geevarghese, M.D. (NPI: 1184747206) practices cardiology in the San Angelo, TX market, with the plurality of this provider's patient population coming from Tom Green, TX. This provider's primary affiliated billing organization is SHANNON CLINIC (NPI: 1770587149; TIN: 752600873) and primary practice location at 76903-5400. Geevarghese is affiliated with the Caravan Health ACO 43 LLC (ACO ID: A4974) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Geevarghese's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,606 traditional Medicare patients, billed 5,262 HCPCS/CPT codes, and received $403,868 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 8,772 prescription claims across 1,160 beneficiaries totaling $802,807 in drug costs, led by Eliquis (Apixaban). DME data shows 18 claims. Open Payments data shows 14 records totaling $292. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $249,407 and ending at $403,868. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $206,503 to $802,807. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $28,520 and ending at $47,143.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,852	10,444	$249,407
2016	1,828	13,365	$332,919
2017	1,948	13,526	$381,626
2018	1,981	13,481	$410,040
2019	1,842	11,857	$426,080
2020	1,772	11,377	$450,745
2021	1,777	9,764	$311,231
2022	1,678	7,978	$237,392
2023	1,667	5,732	$310,411
2024	1,606	5,262	$403,868

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	400	3,381	$206,503
2016	433	3,410	$241,727
2017	539	4,273	$296,847
2018	594	5,004	$384,787
2019	646	5,015	$434,347
2020	789	6,338	$595,005
2021	921	6,741	$643,416
2022	952	6,785	$670,951
2023	1,022	7,569	$708,046
2024	1,160	8,772	$802,807

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	24	$27,736
2018	N/R	54	$38,221
2019	N/R	38	$56,167
2020	11	27	$60,876
2021	14	28	$63,157
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	18	$47,143

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	908	1,401	$88
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	795	846	$50
93228	Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional	230	233	$18
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	378	513	$10
36415	Insertion of needle into vein for collection of blood sample	461	613	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	385	21,896	$405,516
Brilinta	Ticagrelor	84	5,048	$72,777
Xarelto	Rivaroxaban	47	3,210	$57,498
Entresto	Sacubitril/Valsartan	51	2,702	$57,212
Repatha Sureclick	Evolocumab	50	2,248	$42,802

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0606	Automatic external defibrillator, with integrated electrocardiogram analysis, garment type	Y	N/R	18	$47,143

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$292	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Samia Benslimane Geevarghese, M.D.?

Tedicare shows public-source Medicare data for Samia Benslimane Geevarghese, M.D. (NPI 1184747206), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samia Benslimane Geevarghese, M.D. have ACO affiliation data?

Samia Benslimane Geevarghese, M.D. is shown with ACO affiliation data for Caravan Health ACO 43 LLC (MSSP, ACO ID A4974) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Samia Benslimane Geevarghese, M.D.?

Samia Benslimane Geevarghese, M.D. is linked to SHANNON CLINIC (billing NPI 1770587149) in the available physician profile data.

Does Samia Benslimane Geevarghese, M.D. have Open Payments data?

Samia Benslimane Geevarghese, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.